BackgroundMaxillary sinus augmentation (MSA) is a standard and predictable procedure to increase bone height in the atrophic posterior maxilla. Many biomaterials are employed in this technique; however, autologous platelet concentrates have been found to reduce clinical recovery time and improve bone gain in MSA. PurposeThis study aimed to compare the radiographic, histomorphometric, and implant stability outcomes of titanium-prepared platelet-rich fibrin (T-PRF) and deproteinized bovine bone mineral (DBBM) in a two-stage MSA technique. Study design, setting, sampleThis randomized controlled split-mouth study included patients requiring bilateral two-stage MSA at the Periodontology Department of Kutahya Health Sciences University between March 2022 and April 2023. Patients with systemic comorbidities and residual bone height >5 mm in the bilateral posterior maxilla were excluded. Predictor variableThe predictor variable was the two-stage MSA technique. Each surgical site was randomly assigned to the T-PRF or DBBM group for two-stage MSA. Main outcome variablesThe primary outcome was the histomorphometric evaluation of the percentage of new bone (PoNB) between the two groups. Secondary outcomes included radiographic evaluation of total bone height (ToBH), bone gain (BG), bone density (BD), and graft volume (GV) on CBCT 6 months post-MSA, clinical assessment of primary implant stability at implant placement and secondary stability 3 months postplacement, and histomorphometric evaluation of the percentage of residual particles, percentage of connective tissue, and percentage of blood vessels from bone biopsy samples collected 6 months after MSA. CovariatesAge, sex, periodontitis susceptibility, and smoking status were treated as covariates. AnalysesThe Wilcoxon signed-rank test was used for bivariate comparisons between two groups, and the Pearson or Spearman test was used to analyze correlations of variables within groups. A p value ≤0.05 was considered statistically significant. ResultsThe sample was composed 10 patients with bilateral maxillary sinuses, 20 MSA regions, 8 (80%) male and 2 (20%) female with a mean age of 51.30 (9.06) yr. The PoNB was 19.48 ± 14.60 μm2 in the T-PRF group and 8.31 ± 5.47 μm2 in the DBBM group, and there was no statistically significant difference between the groups (p = 0.074). Radiographic measurements showed ToBH, GV, and BD values of 10.64 ± 3.96 mm, 989.89 ± 523.07 mm3, and 192.09 ± 127.90 HU in the T-PRF group and 14.25 ± 1.65 mm, 1519.39 ± 432.61 mm3, and 492.77 ± 117.35 HU in the DBBM group, respectively. ToBH, GV, and BD values were statistically significant between the groups (p = 0.01 and p = 0.00). Primary and secondary implant stability in the T-PRF group were 71.11 ± 12.48 ISQ and 68.03 ± 6.81 ISQ, respectively, compared with 67.94 ± 19.84 ISQ and 72.46 ± 11.21 ISQ in the DBBM group. The difference was not statistically significant between the groups (p = 0.41 and p = 0.33).” Conclusion and relevanceAlthough T-PRF demonstrated inferior radiographic outcomes compared with DBBM during the initial 6-month healing phase, both techniques yielded comparable results regarding new bone formation and implant stability. Further research is warranted to explore the efficacy of different T-PRF applications in MSA. This trial is registered at ClinicalTrials.gov (NCT05596084).
Read full abstract